SciTalent’s Post

I saw this in @Nature and thought we have lost the plot. Why does everything have to have a human-directed purpose?  Can’t we just enjoy house plants for the joy of it? French biotech startup Neoplants just launched its first air-purifying house plant in the US. The bioengineered plants can, according to the company, replace 20 regular plants in terms of air-cleaning power. Do you agree? #wisdom #transformationalleadership #riskmanagement #GettingStuffDone #AI If you are interested in this Post or want hear more about the amazing work we do with our clients please follow us on LinkedIn @defyexpectations.co.uk Thank You, we really appreciate our followers!

I saw this in @Nature and thought we have lost the plot. Why does everything have to have a human-directed purpose?  Can’t we just enjoy house plants for the joy of it? French biotech startup Neoplants just launched its first air-purifying house plant in the US. The bioengineered plants can, according to the company, replace 20 regular plants in terms of air-cleaning power. Do you agree? #wisdom #transformationalleadership #riskmanagement #GettingStuffDone #AI If you are interested in this Post or want hear more about the amazing work we do with our clients please follow us on LinkedIn @defyexpectations.co.uk Thank You, we really appreciate our followers!

𝗦𝘆𝗻𝗕𝗶𝗼 𝗳𝗿𝗼𝗺 𝗟𝗮𝗯 𝘁𝗼 𝗠𝗮𝗿𝗸𝗲𝘁: 𝗩𝗖 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀 𝗳𝗼𝗿 𝗗𝗲𝗲𝗽 𝗧𝗲𝗰𝗵 𝗦𝘁𝗮𝗿𝘁𝘂𝗽𝘀 Synthetic biology (#SynBio) isn't just about science; it's also about how these scientific innovations are turned into products and solutions that meet market needs. Its applications are extensive, ranging from enhancing food flavors to revolutionizing carbon sequestration practices through innovative uses of natural systems and genetic engineering. However, the path from #lab to #market can be challenging for #founders, from building a scalable plan to navigating regulatory matters. We had the pleasure of hosting Chloë Payne, Principal at Ponderosa Ventures, to cover the basics of the SynBio industry and help aspiring #STEM founders take their first steps into #entrepreneurship. Key themes covered: 🧬 Understanding Synthetic Biology (SynBio) and Its Applications 🗺️ Navigating Regulatory Scenarios in the Food Industry 🎯 Pricing Strategy Basics for SynBio Innovations 📈 Capital Efficiency and Scalability in Synthetic Biology Innovation 🎯 Green Lights and Red Flags for VCs in Early-Stage SynBio > Catch the full conversation here: https://lnkd.in/ebQp34tm #startup #startups #innovation #technology #manufacturing #industry #vcs #venturecapital #techtransfer #deeptech #hardtech #industry #tech #strategy #founders #technology #phd #science #foodtech #biotech #DeepTechCatalyst ----- 📣 Follow The Scenarionist to get exclusive insights at the intersection of Deep Tech and Venture Capital, every week!

Techbio startups play at the most exciting and bullish end of the healthcare spectrum, researching the world’s most complex diseases and ailments. But following a flurry of funding activity, how are European biotech’s faring in 2024? Where are scaleups going next? And what’s next for the sector? Our CEO and cofounder Nicolas Wolikow will be leading a roundtable discussion at Sifted Summit on October 2nd at 13:10, titled Techbio 2024: The state of play, dissected #biotech #techbio #healthtech #startup

#global #venture #capital #deals PictorLabs Inc lands $30M for its AI-powered histopathology solution Ferrum Health, Inc. Health secures $16M to help health systems deploy clinical AI algorithms Smart baby monitor maker Harbor locks down $7M AI-driven women’s health insights platform Cercle closes on $6M Canopie seeds $3.7M for maternal mental healthcare platform Vicebio, a UK-based company biotech developing novel vaccines for respiratory illnesses, raised a $100 million Series B led by TCGX. Harmonic raised a $75 million Series A led by Sequoia. It values the Bay Area-based AI company at $325 million. Route 92 Medical, which specializes in technology for treating stroke, extended its Series F with $50 million led by Novo Holdings, bringing the round's total to $82 million. Pyka, maker of autonomous-flying crop dusting and cargo planes, raised a $40 million Series B led by Obvious Ventures. Superconducting-wire manufacturer MetOx International received $25 million to extend its Series B from investors including Centaurus Capital and New System Ventures, Axios reported. Clean energy provider David Energy, based in New York, raised a $23 million Series A1 led by Cathay Innovation. France's Jump, which offers a platform for freelancers, raised an €11 million Series A led by Breega. FluoRok, a UK-based startup that developed a method for accessing fluorochemicals used in the energy transition and healthcare, raised £7.7 million led by BGF.

🤖🔬 Cradle, a platform for AI-powered protein engineering, has raised $73 million in Series B funding. The investment will be used to expand the company’s wet lab to generate additional datasets that will be used to train its models to address a growing array of challenges and modalities. 📈 The round was led by IVP, with participation from previous investors Index Ventures and Kindred Capital VC. This round takes the total investment raised by Cradle to date to over $100 million. Cradle will also expand its engineering team to further improve its ML capabilities to better generalise across tasks and handle more complex proteins. 🤖 Read more here: https://lnkd.in/e_-JghVT Elise de Reus Stef van Grieken Alex Lim #tech #funding #news #VC #startup #investment #innovation #technology #GenAI #biotech

[𝐌𝐚𝐲 𝗿𝗲𝗽𝗼𝗿𝘁] 𝗡𝗲𝘄 𝘀𝘁𝗮𝗿𝘁𝘂𝗽 𝗹𝗮𝘂𝗻𝗰𝗵𝗲𝘀 𝗮𝗻𝗱 𝘀𝘁𝗲𝗮𝗹𝘁𝗵 𝗮𝗰𝘁𝗶𝘃𝗶𝘁𝘆 𝗶𝗻 🇩🇪 𝗚𝗲𝗿𝗺𝗮𝗻𝘆, 🇨🇭 𝗦𝘄𝗶𝘁𝘇𝗲𝗿𝗹𝗮𝗻𝗱 & 🇦🇹 𝗔𝘂𝘀𝘁𝗿𝗶𝗮 In this report: • A pioneering biotech platform focused on decoding and manipulating RNA modifications for targeted cancer therapies 💊 • A platform providing artists with immediate cash offers in exchange for a percentage of their future music streaming revenues 🎵 • A digital B2B broker for timber procurement, connecting construction companies directly with sawmills for seamless transactions 🌲 • A geochemical verification system to authenticate the origin of mineral resources, ensuring supply chain compliance and traceability ⛏️ • An AI-driven tool making genomic data actionable to enhance patient care and accelerate drug discovery 🧬 • Technology aiming to automate and enhance administrative processes for public sector workers using machine learning 📑 • An AI-powered solution addressing energy management challenges with predictive analytics and smart grid integration ⚡ • An infrastructure solution supporting the burgeoning cannabis industry in Europe, focusing on sustainable cultivation practices 🌿 Read the full report: https://lnkd.in/dUKvVucv Until next time! #techstartups #startups #vc #preseed #angelinvestors #emergingtech #DACH #venturecapital

New Post: Meet the Finnish biotech startup bringing a long lost mycoprotein to your plate - https://lnkd.in/gmyMMaDT - The best known mycoprotein is probably Quorn, a meat substitute that’s fast approaching its 40th birthday. But Finnish biotech startup Enifer is cooking up something even older: Its proprietary single-cell fungus-based protein, branded Pekilo, was originally developed in the 1960s and ’70s — by, of all things, the local paper industry. The focus back then © 2024 TechCrunch. All rights reserved. For personal use only. - #news #business #world -------------------------------------------------- Download: Stupid Simple CMS - https://lnkd.in/g4y9XFgR -------------------------------------------------- or download at SourceForge - https://lnkd.in/gNqB7dnp

GeekWire has me listed as one of the top startup CEOs again this year. I've posted the link below where you can vote for your favorite CEO. 😁 Why vote for SEngine Precision Medicine's work? Well, this article in Nature is a pretty good reason. We're making huge differences in patients' lives. https://lnkd.in/dfbxwXJ4 #geekwire #vote #functionalmedicine #functionalprecisionmedicine #oncologyresearch #paristest https://lnkd.in/d6hvZF-E

Briefly Bio launches with $1.2m Pre-Seed Funding to Make Complex Lab Experiments Reproducible Briefly Bio, a biotech startup simplifying complex lab processes, has launched with $1.2 million in pre-seed funding. Co-founded in 2022 by Harry Rickerby, Katya Putintseva, and Staffan Piledahl, the company has launched innovative software to make lab work easily reproducible. It allows scientists to capture their work clearly and share it consistently. According to the company’s announcement reported by Health Tech Digital, the pre-seed round was spearheaded by Compound VC, with a significant contribution from Tiny VC, NP-Hard Ventures, and multiple angel investors from the biotechnology and technology sectors. Read more: https://lnkd.in/gwnd-Jzt #fundingnews #FundingOpportunity #StartupFunding #PreSeed #StartupSuccess #HealthcareNews #LabTechnology #HealthcareFunding #nextdigitalhealth #Wi4 #vineetagrawal